One important starting point towards such development is the virus' genome sequence, which is currently available (GenBank ID: MN908947.3). It has been realized that 2019-nCoV shares 82 % sequence identity with severe acute respiratory syndrome-related coronavirus (SARS-CoV). Thus, past findings from medicinal chemistry studies on SARS-CoV may directly be used in current research efforts on 2019-nCoV.